Torrent

New tiopronin delayed-release tablets launch with patient support for the treatment of cystinuria in the US

Retrieved on: 
星期一, 五月 13, 2024
FDA, Health, Research, Pharmaceutical, Science, Biotechnology, Partnership, Incidence, Patient, Rash, Lymphadenopathy, Full, Diarrhea, Birth, Milk, Label, Generic, Risk, Tiopronin, Food, Pregnancy, Education, Nausea, Glomerulonephritis, Fever, Arthralgia, SVP, Vomiting, Tablet, Cystinuria, Torrent, Kidney stone disease, Kidney, Breastfeeding, Miscarriage, Proteinuria, Fatigue, Hyperthermia, Child, Lactation, Cycle, Use, Nephrotic syndrome, Birth control

In addition, a Patient Nutrition Program* will be available to reinforce the clinic’s nutrition plan,” says Chikai Lai, SVP & Chief Commercial Officer, Cycle.

Key Points: 
  • In addition, a Patient Nutrition Program* will be available to reinforce the clinic’s nutrition plan,” says Chikai Lai, SVP & Chief Commercial Officer, Cycle.
  • Alcohol: Tiopronin is released faster from tiopronin delayed-release tablets in the presence of alcohol and the risk for adverse events associated with tiopronin delayed-release tablets when taken with alcohol is unknown.
  • Because of the potential for serious adverse reactions, including nephrotic syndrome, advise patients that breastfeeding is not recommended during treatment with tiopronin delayed-release tablets.
  • Tiopronin delayed-release tablets are not approved for use in pediatric patients weighing less than 20 kg or in pediatric patients unable to swallow tablets.

New US product, ORMALVI™ (dichlorphenamide) tablets, launches for Primary Periodic Paralysis (PPP) treatment

Retrieved on: 
星期三, 五月 8, 2024
FDA, General Health, Pharmaceutical, Health, Fetus, Cardiomyopathy, Torrent, Acidosis, Respiratory acidosis, Full, Diclofenamide, Risk, Pregnancy, Cognitive disorder, Milk, Aspirin, Metabolic acidosis, Dysgeusia, Hyperkalemia, Aplastic anemia, Partnership, PPP, Agranulocytosis, Anorexia nervosa, Human, Carbonic anhydrase inhibitor, SVP, Tablet, Incidence, Patient, Nursing, Lethargy, Serum, Hyperkalemic periodic paralysis, Diagnosis, Myopathy, Hypokalemic periodic paralysis, Paralysis, Paresthesia, Cycle, Stevens–Johnson syndrome, Hypokalemia, Quality of life, Argyreia nervosa, Sulfonamide, Coma, Pharmaceutical industry

We want to provide them with the support that they require to effectively manage their PPP.

Key Points: 
  • We want to provide them with the support that they require to effectively manage their PPP.
  • ORMALVI™ is an oral carbonic anhydrase inhibitor indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants.
  • Simply Stated: Research Updates in Periodic Paralysis - Quest | Muscular Dystrophy Association [online] Available at: https://mdaquest.org/simply-stated-research-updates-in-periodic-paralysis Accessed 23 Nov. 2023.
  • The impact of permanent muscle weakness on quality of life in periodic paralysis: a survey of 66 patients.

Ranger Energy Services, Inc. Announces Q1 2024 Results

Retrieved on: 
星期二, 五月 7, 2024
Energy, Other Energy, Oil, Gas, Permian, Torrent, Tubing (recreation), Weather, Safety, Depreciation, Depression, Free cash flow, High, Ancillary services (electric power), Pressure, Acquisition, Share repurchase, Water, Growth

Ranger Energy Services, Inc. (NYSE: RNGR) (“Ranger” or the “Company”) announced today its results for the first quarter ended March 31, 2024.

Key Points: 
  • Ranger Energy Services, Inc. (NYSE: RNGR) (“Ranger” or the “Company”) announced today its results for the first quarter ended March 31, 2024.
  • Stuart Bodden, Ranger’s Chief Executive Officer, commented, “This quarter’s results presented Ranger with a unique set of challenges that adversely impacted multiple service lines.
  • As mentioned in our year-end investor call, 2024 got off to a slow start.
  • For the first quarter of 2024, revenue was $136.9 million, a decrease from $157.5 million in the prior year period.

Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent

Retrieved on: 
星期一, 二月 5, 2024
Patent, The Orange Book, New Drug Application, Intellectual property, Central nervous system, FDA, Orange Book, Torrent, District court, Food, CNS, Torrent Pharmaceuticals, IP, Topiramate

ROCKVILLE, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that the United States District Court for the District of New Jersey ruled that Torrent Pharmaceuticals Ltd. and its subsidiary, Torrent Pharma Inc., infringed U.S. Patent Nos.

Key Points: 
  • ROCKVILLE, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that the United States District Court for the District of New Jersey ruled that Torrent Pharmaceuticals Ltd. and its subsidiary, Torrent Pharma Inc., infringed U.S. Patent Nos.
  • 8,992,989; 9,549,940; and 9,622,983 by submitting to the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) seeking permission to market a generic version of Trokendi XR® before the expiration of Supernus’ patents.
  • “We are very pleased with the District Court’s ruling that Torrent infringed our Trokendi XR® patents and the reaffirmation of the validity of those patents,” stated Jack A. Khattar, President and Chief Executive Officer of Supernus Pharmaceuticals.
  • The Orange Book lists a total of ten patents as covering Trokendi XR.

Salvo Technologies Announces the Formation of Torrent Photonics

Retrieved on: 
星期一, 一月 1, 2024
Growth, Torrent, Photonics, Graflex, Microscope

LARGO, Fla., Jan. 1, 2024 /PRNewswire-PRWeb/ -- Salvo Technologies announced today the formation of Torrent Photonics LLC ("Torrent'). The formation of Torrent is the result of the Company's integration of its photonics entities into a newly formed business dedicated solely to the Photonics industry.

Key Points: 
  • Salvo Technologies announced today the formation of Torrent Photonics LLC ("Torrent').
  • The formation of Torrent is the result of the Company's integration of its photonics entities into a newly formed business dedicated solely to the Photonics industry.
  • LARGO, Fla., Jan. 1, 2024 /PRNewswire-PRWeb/ -- Salvo Technologies announced today the formation of Torrent Photonics LLC ("Torrent').
  • The formation of Torrent is the result of the Company's integration of its photonics entities into a newly formed business dedicated solely to the Photonics industry.

1 HOTELS LAUNCHES LONDON'S FIRST NATURE-DRIVEN HOTEL EXPERIENCE

Retrieved on: 
星期一, 十一月 6, 2023
Honey, BREEAM, Regent Street, Berkeley Square, Farm, Sea, Sellers, Royal, Wood, Dover Street, Health, Glass, Carbon, Neighbours, Terrace, Torrent, Buckingham Palace, Plant, Magic, Culture, Technogym, Rejuvenation, United Kingdom, Ageing, Kate, Bond Street, Restaurant, Snack, Champagne, Apéritif and digestif, Orkney, Royal Academy of Arts, Water, System, Beer, Biophilic design, Epping, Mount Street, London, Tree, Knickerbocker glory, Dion, Nature, RS, Environment, Audi Q8 e-tron, Collection, Michelin, Tourism, Nightclub, Interior design, Hotel, Wine, Cotswolds, Rainforest

LONDON, Nov. 6, 2023 /PRNewswire/ -- 1 Hotels, the nature-inspired mission-driven hotel brand founded by hospitality visionary Barry Sternlicht, announces the official opening of 1 Hotel Mayfair, its UK flagship and first European destination, developed in collaboration with Crosstree Real Estate Partners. Located on a fashionable corner of historic Mayfair overlooking the mature trees of Green Park, 1 Hotel Mayfair brings the beauty of nature to central London through vertical landscapes, sustainable design, farm-to-table food, and nature-inspired immersive experiences.

Key Points: 
  • "At 1 Hotel Mayfair, we have meticulously curated a sustainable destination, drawing inspiration from the innate beauty of the natural world that surrounds us.
  • Our brand's purpose-driven ethos seamlessly harmonizes with the vibrant tapestry of London and the illustrious Mayfair district," says SH Hotels & Resorts Chief Executive Officer Raul Leal.
  • "We are delighted to bring 1 Hotels' industry-leading sustainability focus to London as an alternative vision of modern luxury compared to the traditional hotels that dominate Mayfair.
  • With 1 Hotels' signature biophilic design combined with its deep-rooted passion and authenticity around environmental responsibility, 1 Hotel Mayfair is a fresh addition to London's hotel scene," said Sean Arnold & Nick Lyle, Founders, Crosstree Real Estate Partners.

1 HOTELS LAUNCHES LONDON'S FIRST NATURE-DRIVEN HOTEL EXPERIENCE

Retrieved on: 
星期一, 十一月 6, 2023
Honey, BREEAM, Regent Street, Berkeley Square, Farm, Sea, Sellers, Royal, Wood, Dover Street, Health, Glass, Carbon, Neighbours, Terrace, Torrent, Buckingham Palace, Plant, Magic, Culture, Technogym, Rejuvenation, United Kingdom, Ageing, Kate, Bond Street, Restaurant, Snack, Champagne, Apéritif and digestif, Orkney, Royal Academy of Arts, Water, System, Beer, Biophilic design, Epping, Mount Street, London, Tree, Knickerbocker glory, Dion, Nature, RS, Environment, Audi Q8 e-tron, Collection, Michelin, Tourism, Nightclub, Interior design, Hotel, Wine, Cotswolds, Rainforest

LONDON, Nov. 6, 2023 /PRNewswire/ -- 1 Hotels, the nature-inspired mission-driven hotel brand founded by hospitality visionary Barry Sternlicht, announces the official opening of 1 Hotel Mayfair, its UK flagship and first European destination, developed in collaboration with Crosstree Real Estate Partners. Located on a fashionable corner of historic Mayfair overlooking the mature trees of Green Park, 1 Hotel Mayfair brings the beauty of nature to central London through vertical landscapes, sustainable design, farm-to-table food, and nature-inspired immersive experiences.

Key Points: 
  • "At 1 Hotel Mayfair, we have meticulously curated a sustainable destination, drawing inspiration from the innate beauty of the natural world that surrounds us.
  • Our brand's purpose-driven ethos seamlessly harmonizes with the vibrant tapestry of London and the illustrious Mayfair district," says SH Hotels & Resorts Chief Executive Officer Raul Leal.
  • "We are delighted to bring 1 Hotels' industry-leading sustainability focus to London as an alternative vision of modern luxury compared to the traditional hotels that dominate Mayfair.
  • With 1 Hotels' signature biophilic design combined with its deep-rooted passion and authenticity around environmental responsibility, 1 Hotel Mayfair is a fresh addition to London's hotel scene," said Sean Arnold & Nick Lyle, Founders, Crosstree Real Estate Partners.

Ranger Energy Services, Inc. Announces Q4 2022 and Full Year 2022 Financial and Operational Results

Retrieved on: 
星期二, 三月 7, 2023
Oil, Gas, Energy, Storm, December 2022 North American winter storm, Share repurchase, NYSE, Ancillary services (electric power), Ranger, Acquisition, Growth, Environment, Hand, Deleveraging, Management, EBITDA, Public expenditure, Weather, Capital expenditure, Cryptocurrency, Video game, Renting, Bookkeeping, Security (finance), Retail, Airline, Bank, Adjustment, Torrent

Ranger Energy Services, Inc. (NYSE: RNGR) (“Ranger” or the “Company”) announced today its results for the fourth quarter and full year ended December 31, 2022.

Key Points: 
  • Ranger Energy Services, Inc. (NYSE: RNGR) (“Ranger” or the “Company”) announced today its results for the fourth quarter and full year ended December 31, 2022.
  • Ranger’s strong performance is a credit to their hard work and tenacity, and I’m proud to present these results to our investors on their behalf.
  • Net income totaled $7.6 million for the fourth quarter of 2022 compared to $24.4 million for the fourth quarter of 2021.
  • Rig hours for the fourth quarter of 2022 were down 8% compared to 123,000 hours reported in the third quarter of 2022.

Journey Medical Corporation Appoints Joseph Benesch as Interim Chief Financial Officer

Retrieved on: 
星期五, 一月 20, 2023
Torrent, Entrepreneurship, GAAP, Ernst, Torrent Group, Aptalis, Savient pharmaceuticals, NDA, Certified Public Accountant, Wilkes University, LLP, BA, Market for corporate control, Interim, Oxley, Torrent Pharmaceuticals, Pleasure, Sarbanes, Pharmaceutical industry, Finance

The Company also today announced the appointment of Joseph M. Benesch as Interim Chief Financial Officer, effective January 27, 2023.

Key Points: 
  • The Company also today announced the appointment of Joseph M. Benesch as Interim Chief Financial Officer, effective January 27, 2023.
  • Claude Maraoui, Co-Founder, President and Chief Executive Officer of Journey Medical, said, “Joe has been an instrumental member of our finance and accounting team overseeing all functions as Corporate Controller for over a year now.
  • Mr. Maraoui continued, "We want to thank Ernie for his contributions to the Company as Chief Financial Officer.
  • "I look forward to continuing to work with the Journey Medical management team while leading the finance and accounting functions,” commented Mr. Benesch.

After releasing more than 4,000 new products in 2022, Dorman announces 400 new repair solutions in January 2023

Retrieved on: 
星期五, 一月 13, 2023
Cadillac, Dorman, Torrent, GMC, Lincoln Mark LT, Ford Transit, Pathfinder, OE, Ford Motor Company, PTFE, F-150, Equinox, Pontiac, Cassette tape, Rail transport, Nissan

These new releases continue Dorman’s industry-leading innovation that delivered more than 4,000 new products in 2022 alone.

Key Points: 
  • These new releases continue Dorman’s industry-leading innovation that delivered more than 4,000 new products in 2022 alone.
  • Among the new releases this month are several innovative Dorman OE FIX™ repair solutions designed to help save time, save money, and increase reliability.
  • New this month is a cost-saving OE FIX liftgate handle trim kit ( 97943 ) for more than half a million 2013-2019 Nissan Pathfinder SUVs.
  • To learn more about Dorman, take the Dorman Virtual Tour at DormanProducts.com/tour .